Insider · CIK 0001709485
Manuel Litchman MD
Files at MBIO (MUSTANG BIO, INC.). First filing -, latest -.
Manuel Litchman MD files SEC Form 4 as CEO, CFO, president and director at MBIO (MUSTANG BIO, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Manuel Litchman MD has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | MBIO MUSTANG BIO, INC. | FTax withholding COMMON STOCK | -19 | $0.75 | $14 | 1,615 | Apr 27, 2026 |
| Apr 24, 2025 | MBIO MUSTANG BIO, INC. | FTax withholding COMMON STOCK | -27 | $1.24 | $33 | 1,634 | Apr 28, 2025 |
Questions about Manuel Litchman MD
Answered from the filings on this page, as of the latest one.
Is Manuel Litchman MD buying or selling?
Manuel Litchman MD has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Manuel Litchman MD's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Manuel Litchman MD has 0.
Where does Manuel Litchman MD file Form 4?
Manuel Litchman MD has filed Form 4 at MBIO (MUSTANG BIO, INC.) as President, CEO and Interim CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.